Median Technologies SA (EPA:ALMDT)

Market Cap	118.94M
Revenue (ttm)	23.38M
Net Income (ttm)	-21.99M
Shares Out	36.71M
EPS (ttm)	-1.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	328,083
Average Volume	298,380
Open	3.200
Previous Close	3.165
Day's Range	3.170 - 3.425
52-Week Range	1.192 - 5.260
Beta	0.49
RSI	55.70
Earnings Date	Apr 28, 2026

About Median Technologies

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 225
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMDT

Financial Performance

In 2024, Median Technologies's revenue was 22.96 million, an increase of 0.79% compared to the previous year's 22.78 million. Losses were -25.24 million, 9.83% more than in 2023.